Role of Letrozole in Management of Female Infertility; Review Article

被引:0
作者
Messawa, Maha Fouad [1 ]
Omar, Salma Yousef [2 ]
Babagi, Reem Ahmed [3 ]
机构
[1] Heraa Gen Hosp HGH, Mecca, Saudi Arabia
[2] Matern & Children Hosp MCH, Mecca, Saudi Arabia
[3] King Abdullah Med Complex KAMC, Jeddah, Saudi Arabia
关键词
Letrozole; femara; infertility; oral aromatase inhibitor; pregnancy; systematic; AROMATASE INHIBITOR LETROZOLE; FOLLICLE-STIMULATING-HORMONE; OVARIAN STIMULATION; UNEXPLAINED INFERTILITY; FERTILITY PRESERVATION; CLOMIPHENE CITRATE; BREAST-CANCER; WOMEN; PHARMACOKINETICS; GONADOTROPINS;
D O I
10.9734/JPRI/2021/v33i48A33249
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Letrozole is a highly steroidal and selective oral aromatase inhibitor (AI). Serval studies shows that Co-treatment with letrozole significantly reduced gonadotropin consumption and the incidence of Ovarian Hyperstimulation Syndrome in normal/high responders, with pregnancy outcomes comparable to or better than the other groups. In this article we will be looking at role of letrozole in treatment of infertility Methodology: A simple systematic review was carried out, searching databases PubMed, Google Scholar, and EBSCO. The authors extracted qualitative data, and then the author's names, year, study type, methodology, and the result were reported. Results and Conclusion: Letrozole has effectiveness which is near the usage of the Human Menopausal Gonadotrophin in the numbers of pregnancies per cycle but have much less cost which indicates cost effectiveness of the drug. Furthermore, studies show that administration of the drug is effective in inducing pregnancy, with higher dose more than 5mg and 7.5mg more effective.
引用
收藏
页码:260 / 271
页数:12
相关论文
共 49 条
[41]   Comparison of the effects of letrozole and cabergoline on vascular permeability, ovarian diameter, ovarian tissue VEGF levels, and blood PEDF levels, in a rat model of ovarian hyperstimulation syndrome [J].
Sahin, Nur ;
Apaydin, Nesin ;
Toz, Emrah ;
Sivrikoz, Oya Nermin ;
Genc, Mine ;
Turan, Guluzar Arzu ;
Cengiz, Hakan ;
Eskicioglu, Fatma .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2016, 293 (05) :1101-1106
[42]   Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for poor and sub optimal responders? [J].
Shapira, Moran ;
Orvieto, Raoul ;
Lebovitz, Oshrit ;
Nahum, Ravit ;
Aizer, Adva ;
Segev-Zahav, Aliza ;
Haas, Jigal .
JOURNAL OF OVARIAN RESEARCH, 2020, 13 (01)
[43]   Effect of GnRH agonist and letrozole treatment in women with recurrent implantation failure [J].
Steiner, Naama ;
Shrem, Guy ;
Tannus, Samer ;
Dahan, S. Yehuda ;
Balayla, Jacques ;
Volodarsky-Perel, Alexander ;
Tan, Seang-Lin ;
Dahan, Michael H. .
FERTILITY AND STERILITY, 2019, 112 (01) :98-104
[44]   The role of Letrozole (LE) in controlled ovarian stimulation (COS) in patients at high risk to develop ovarian hyper stimulation syndrome (OHSS). A prospective randomized controlled pilot study [J].
Tshzmachyan, Ruzanna ;
Hambartsoumian, Eduard .
JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2020, 49 (02)
[45]   Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate [J].
Tulandi, Togas ;
Martin, James ;
Al-Fadhli, Raedah ;
Kabli, Nadia ;
Forman, Rachel ;
Hitkari, Jason ;
Librach, Clifford ;
Greenblatt, Ellen ;
Casper, Robert F. .
FERTILITY AND STERILITY, 2006, 85 (06) :1761-1765
[46]   Can steroidal ovarian suppression during the luteal phase after oocyte retrieval reduce the risk of severe OHSS? [J].
Wang, Ya-Qin ;
Luo, Jin ;
Xu, Wang-Min ;
Xie, Qin-Zhen ;
Yan, Wen-Jie ;
Wu, Geng-Xiang ;
Yang, Jin .
JOURNAL OF OVARIAN RESEARCH, 2015, 8
[47]  
Zadehmodares Shahrzad, 2012, Acta Med Iran, V50, P18
[48]   Letrozole use during frozen embryo transfer cycles in women with polycystic ovary syndrome [J].
Zhang, Jie ;
Liu, Hongfang ;
Wang, Yun ;
Mao, Xiaoyan ;
Chen, Qiuju ;
Fan, Yong ;
Xiao, Yitao ;
Kuang, Yanping .
FERTILITY AND STERILITY, 2019, 112 (02) :371-377
[49]   A pilot study of gonadotropin-releasing hormone agonist combined with aromatase inhibitor as fertility-sparing treatment in obese patients with endometrial cancer [J].
Zhang, Zhibo ;
Huang, Huifang ;
Feng, Fengzhi ;
Wang, Jinhui ;
Cheng, Ninghai .
JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 30 (04)